메뉴 건너뛰기




Volumn 9, Issue 4, 2014, Pages

Development of an adverse drug reaction risk assessment score among hospitalized patients with chronic kidney disease

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ALTEPLASE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BENZODIAZEPINE; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENOXAPARIN; FONDAPARINUX; FUROSEMIDE; HEPARIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PARACETAMOL; PROPRANOLOL; SULFONYLUREA; WARFARIN; ANTICOAGULANT AGENT;

EID: 84899693167     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095991     Document Type: Article
Times cited : (30)

References (40)
  • 2
    • 0032522873 scopus 로고    scopus 로고
    • Incidence of adverse drug reactions in hospitalized patients: A meta- analysis of prospective studies
    • DOI 10.1001/jama.279.15.1200
    • Lazarou J, Pomeranz BH, Corey PN (1998) Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies. JAMA 279: 1200-1205. (Pubitemid 28193431)
    • (1998) Journal of the American Medical Association , vol.279 , Issue.15 , pp. 1200-1205
    • Lazarou, J.1    Pomeranz, B.H.2    Corey, P.N.3
  • 5
    • 70349603042 scopus 로고    scopus 로고
    • Pharmacokinetics and dosage adjustment in patients with renal dysfunction
    • Verbeeck RK, Musuamba FT (2009) Pharmacokinetics and dosage adjustment in patients with renal dysfunction. Eur J Clin Pharmacol 65: 757-773.
    • (2009) Eur J Clin Pharmacol , vol.65 , pp. 757-773
    • Verbeeck, R.K.1    Musuamba, F.T.2
  • 9
    • 77954574142 scopus 로고    scopus 로고
    • Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: The GerontoNet ADR risk score
    • Onder G, Petrovic M, Tangiisuran B, Meinardi MC, Markito-Notenboom WP, et al. (2010) Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. Arch Intern Med 170: 1142-1148.
    • (2010) Arch Intern Med , vol.170 , pp. 1142-1148
    • Onder, G.1    Petrovic, M.2    Tangiisuran, B.3    Meinardi, M.C.4    Markito-Notenboom, W.P.5
  • 11
    • 0033596104 scopus 로고    scopus 로고
    • Prevention Study Group. Patient risk factors for adverse drug events in hospitalized patients
    • Bates DW, Miller EB, Cullen DJ, Burdick L, Williams L, et al. (1999) Prevention Study Group. Patient risk factors for adverse drug events in hospitalized patients. Arch of Intern Med 159: 2553-2560.
    • (1999) Arch of Intern Med , vol.159 , pp. 2553-2560
    • Bates, D.W.1    Miller, E.B.2    Cullen, D.J.3    Burdick, L.4    Williams, L.5
  • 12
    • 1542741001 scopus 로고    scopus 로고
    • Iatrogenic illness on a general medical service at a university hospital
    • Steel K, Gertman PM, Crescenzi C, Anderson J (2004) Iatrogenic illness on a general medical service at a university hospital. Qual Saf Health Care 13: 76-80.
    • (2004) Qual Saf Health Care , vol.13 , pp. 76-80
    • Steel, K.1    Gertman, P.M.2    Crescenzi, C.3    Anderson, J.4
  • 13
    • 0037067909 scopus 로고    scopus 로고
    • Improving the quality of medication use in elderly patients: A not-so-simple prescription
    • Gurwitz JH, Rochon P (2002) Improving the quality of medication use in elderly patients: a not-so-simple prescription. Arch Intern Med 162:1670-1672.
    • (2002) Arch Intern Med , vol.162 , pp. 1670-1672
    • Gurwitz, J.H.1    Rochon, P.2
  • 14
    • 17644380282 scopus 로고    scopus 로고
    • Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients
    • DOI 10.1001/archinte.165.7.790
    • Corsonello A, Pedone C, Corica F, Mussi C, Carbonin P, et al. (2005) Gruppo Italiano di Farmacovigilanza nell' Anziano (GIFA) Investigators. Concealed renal insufficiency and adverse drug reactions in elderly hospitalized patients. Arch Intern Med 165:790-795. (Pubitemid 40569433)
    • (2005) Archives of Internal Medicine , vol.165 , Issue.7 , pp. 790-795
    • Corsonello, A.1    Pedone, C.2    Corica, F.3    Mussi, C.4    Carbonin, P.5    Incalzi, R.A.6
  • 15
    • 70349092256 scopus 로고    scopus 로고
    • Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department
    • Helldén A, Bergman U, von Euler M, Hentschke M, Odar-Cederlöf I, et al. (2009) Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department. Drugs Aging 26: 595-606.
    • (2009) Drugs Aging , vol.26 , pp. 595-606
    • Helldén, A.1    Bergman, U.2    Von Euler, M.3    Hentschke, M.4    Odar-Cederlöf, I.5
  • 17
    • 0003406703 scopus 로고    scopus 로고
    • World Health Organization Tenth Revision (ICD-10) Geneva, Switzerland. World Health Organization
    • World Health Organization (2004) International Classification of Diseases, Tenth Revision (ICD-10). Geneva, Switzerland. World Health Organization.
    • (2004) International Classification of Diseases
  • 18
    • 0033574249 scopus 로고    scopus 로고
    • A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation
    • Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, et al. (1999) Modification of Diet in Renal Disease Study Group: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130: 461-470. (Pubitemid 29135798)
    • (1999) Annals of Internal Medicine , vol.130 , Issue.6 , pp. 461-470
    • Levey, A.S.1    Bosch, J.P.2    Lewis, J.B.3    Greene, T.4    Rogers, N.5    Roth, D.6
  • 19
    • 0036176161 scopus 로고    scopus 로고
    • K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
    • National Kidney Foundation
    • National Kidney Foundation (2002) K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 (Suppl 1):S1-S266.
    • (2002) Am J Kidney Dis , vol.39 , Issue.SUPPL. 1
  • 20
    • 0034619028 scopus 로고    scopus 로고
    • Adverse drug reactions: Definitions, diagnosis, and management
    • Edwards IR, Aronson JK (2000) Adverse drug reactions: definitions, diagnosis, and management. Lancet 356: 1255-1259.
    • (2000) Lancet , vol.356 , pp. 1255-1259
    • Edwards, I.R.1    Aronson, J.K.2
  • 21
    • 0037699987 scopus 로고    scopus 로고
    • Adverse drug event trigger tool: A practical methodology for measuring medication related harm
    • Rozich JD, Haraden CR, Resar RK (2003) Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care 12: 194-200. (Pubitemid 36723946)
    • (2003) Quality and Safety in Health Care , vol.12 , Issue.3 , pp. 194-200
    • Rozich, J.D.1    Haraden, C.R.2    Resar, R.K.3
  • 22
  • 23
    • 84899683849 scopus 로고    scopus 로고
    • British Medical Association, Royal Pharmaceutical Society of Great Britain British National Formulary. London: BMA, RPS, (No 64)
    • British Medical Association, Royal Pharmaceutical Society of Great Britain (2012) British National Formulary. London: BMA, RPS, (No 64).
    • (2012)
  • 24
    • 0019799332 scopus 로고
    • A method for estimating the probability of adverse drug reactions
    • Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, et al. (1981) A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30: 239-245. (Pubitemid 12149145)
    • (1981) Clinical Pharmacology and Therapeutics , vol.30 , Issue.2 , pp. 239-245
    • Naranjo, C.A.1    Busto, U.2    Sellers, E.M.3
  • 25
    • 0035080356 scopus 로고    scopus 로고
    • Prognostic modeling with logistic regression analysis: In search of a sensible strategy in small data sets
    • Steyerberg EW, Eijkemans MJC, Harrell FE, Habbema JDF (2001) Prognostic modeling with logistic regression analysis in search of a sensible strategy in small data sets. Med Decis Making 21: 45-56. (Pubitemid 32245030)
    • (2001) Medical Decision Making , vol.21 , Issue.1 , pp. 45-56
    • Steyerberg, E.W.1    Eijkemans, M.J.C.2    Harrell Jr., F.E.3    Habbema, J.D.F.4
  • 26
    • 33847382959 scopus 로고    scopus 로고
    • Relaxing the rule of ten events per variable in logistic and cox regression
    • DOI 10.1093/aje/kwk052
    • Vittinghoff E, McCulloch CE (2007) Relaxing the rule of ten events per variable in logistic and cox regression. Am J Epidemiol 165: 710-718. (Pubitemid 46348374)
    • (2007) American Journal of Epidemiology , vol.165 , Issue.6 , pp. 710-718
    • Vittinghoff, E.1    McCulloch, C.E.2
  • 27
    • 0020063002 scopus 로고
    • A review of goodness of fit statistics for use in the development of logistic regression models
    • Lemeshow S, Hosmer DW (1982) A review of goodness of fit statistics for use in the development of logistic regression models. Am J Epidemiol 115: 92-106. (Pubitemid 12205725)
    • (1982) American Journal of Epidemiology , vol.115 , Issue.1 , pp. 92-106
    • Lemeshow, S.1    Hosmer Jr., D.W.2
  • 28
    • 73849094087 scopus 로고    scopus 로고
    • Assessing the performance of prediction models: A framework for traditional and novel measures
    • Steyerberg EW, Vickers AJ, Cook NR, Gerds T, Gonen M, et al. (2010) Assessing the performance of prediction models: a framework for traditional and novel measures. Epidemiology 21: 128-138.
    • (2010) Epidemiology , vol.21 , pp. 128-138
    • Steyerberg, E.W.1    Vickers, A.J.2    Cook, N.R.3    Gerds, T.4    Gonen, M.5
  • 29
    • 38849091997 scopus 로고    scopus 로고
    • Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
    • DOI 10.1002/sim.2929
    • Pencina MJ, D' Agostino RB, D' Agostino RB, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 27: 157-172. (Pubitemid 351193639)
    • (2008) Statistics in Medicine , vol.27 , Issue.2 , pp. 157-172
    • Pencina, M.J.1    D'Agostino Sr., R.B.2    D'Agostino Jr., R.B.3    Vasan, R.S.4
  • 35
    • 0035213015 scopus 로고    scopus 로고
    • Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department
    • DOI 10.1067/mem.2001.119456
    • Hohl CM, Dankoff J, Colacone A, Afilalo M (2001) Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med 38: 666-671. (Pubitemid 33131567)
    • (2001) Annals of Emergency Medicine , vol.38 , Issue.6 , pp. 666-671
    • Hohl, C.M.1    Dankoff, J.2    Colacone, A.3    Afilalo, M.4
  • 36
    • 79955683771 scopus 로고    scopus 로고
    • Association between glomerular filtration rate and adverse drug reactions in elderly hospitalized patients
    • Corsonello A, Pedone C, Lattanzio F, Onder G, Incalzi R (2011) Association between glomerular filtration rate and adverse drug reactions in elderly hospitalized patients. Drugs Aging 28: 379-390.
    • (2011) Drugs Aging , vol.28 , pp. 379-390
    • Corsonello, A.1    Pedone, C.2    Lattanzio, F.3    Onder, G.4    Incalzi, R.5
  • 38
    • 33845235462 scopus 로고    scopus 로고
    • The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease
    • DOI 10.1038/sj.ki.5001934, PII 5001934
    • Charytan D, Kuntz RE (2006) The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease. Kidney Int 70: 2021-2030. (Pubitemid 44863392)
    • (2006) Kidney International , vol.70 , Issue.11 , pp. 2021-2030
    • Charytan, D.1    Kuntz, R.E.2
  • 39
    • 77953291706 scopus 로고    scopus 로고
    • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis
    • Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, et al. (2010) Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375: 2073-2081.
    • (2010) Lancet , vol.375 , pp. 2073-2081
    • Matsushita, K.1    Van Der Velde, M.2    Astor, B.C.3    Woodward, M.4    Levey, A.S.5
  • 40
    • 34548575455 scopus 로고    scopus 로고
    • Limitations of applying summary results of clinical trials to individual patients: The need for risk stratification
    • DOI 10.1001/jama.298.10.1209
    • Kent DM, Hayward RA (2007) Limitations of applying summary results of clinical trials to individual patients: The need for risk stratification. JAMA 298: 1209-1212. (Pubitemid 47403108)
    • (2007) Journal of the American Medical Association , vol.298 , Issue.10 , pp. 1209-1212
    • Kent, D.M.1    Hayward, R.A.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.